Protagonist Therapeutics price target raised to $165 from $137 at Citizens
Upside potential increased by target raise.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential increased by target raise.
What happened, with direct paths to the underlying reporting
Citizens raises PTGX target to $165 from $137; current price $132.02.
Target: $165
Posted price: $132.02
Analyst firm: Johnson Rice
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.